Table 3.
Adenosine receptor affinities and selectivities of 2-phenylimidazo[2,1-i]purin-5-one derivatives
| ||||||||
|---|---|---|---|---|---|---|---|---|
| Compd | R2 | R4 | R8 |
Ki (nM)±SEM or % displacement at concentration indicated (in brackets) |
||||
| A1 Affinity rat brain cortical membranes [3H]CCPA |
A1 Affinity human brain cortical membranes [3H]CCPA |
A2A Affinity rat brain striatal membranes [3H]MSX-2 |
A2A Affinity human brain caudate-putamen membranes [3H]CGS-21680 |
A3 Affinity human recombinant receptors [125I]AB-MECA |
||||
| N1/N9-unsubstituted imidazopurinones | ||||||||
| R-1 (PSB-11) | Phenyl | Methyl | (R)-Ethyl | 44013a | 1640±50 | 210013b | 1280±430 | 2.313 3.5±0.39c |
| S-1 | Phenyl | Methyl | (S)-Ethyl | 11513a | 305±25 | 330013b | 440±80 | 9.813 |
| 2 | Phenyl | Methyl | H | 2230±200 | n.d.d | 14,100±4,460 | n.d. | 18,900±3200 |
| S-3 | Phenyl | Propyl | (S)-Ethyl | 7.4±1.4 | 98±12 | 863±203 | 3400±2400 | 860±640 |
| S-4 | 3,4-Dichlorophenyl | Propyl | (S)-Ethyl | 46±1 | n.d. | 26%e (2.5 μM) | n.d. | 116±17 |
| S-5 | 2-chlorophenyl | Methyl | (S)-Ethyl | 17±1 | 90±11 | 4170±350 | 2500±1200 | 420±340 |
| S-6 | 3-Chlorophenyl | Methyl | (S)-Ethyl | 30±2 | n.d. | 2530±240 | n.d. | 184±129 |
| S-7 | 4-Chlorophenyl | Methyl | (S)-Ethyl | 63±20 | n.d. | 2630±320 | n.d. | 12±1 |
| R-8 (PSB-10) | 2,3,5-Trichlorophenyl | Methyl | (R)-Ethyl | 805±55 | 1700±200 | 6040±260 | 2700±500 | 0.433±0.045c 0.997±0.311f |
| N9-methylated derivatives | ||||||||
| S-9 | 3,4-Dichlorophenyl | Propyl | (S)-Ethyl | 2800±1,100g | 36,000±16,500g | 13,000±2,000g | 6600±600g | 2350±1150f,g |
| R-10 | 2,3,5-Trichlorophenyl | Methyl | (R)-Ethyl | 12%±1e (10 μM) | 35,500±18,500g | 17%±1e (10 μM) | 0%e (10 μM) | 395±55f |
Determined versus [3H]CHA.
Determined versus [3H]CGS21680.
Determined versus [3H]NECA.
n.d. = not determined.
Percentage inhibition at concentration indicated.
Determined versus [3H]PSB-11.
Estimated value; full curve could not be determined due to limited water solubility.